vs

Side-by-side financial comparison of HEALTHY CHOICE WELLNESS CORP. (HCWC) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.

HEALTHY CHOICE WELLNESS CORP. is the larger business by last-quarter revenue ($18.7M vs $13.3M, roughly 1.4× OCULAR THERAPEUTIX, INC). HEALTHY CHOICE WELLNESS CORP. runs the higher net margin — -8.9% vs -488.0%, a 479.1% gap on every dollar of revenue. HEALTHY CHOICE WELLNESS CORP. produced more free cash flow last quarter ($-927.1K vs $-57.1M).

Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.

HCWC vs OCUL — Head-to-Head

Bigger by revenue
HCWC
HCWC
1.4× larger
HCWC
$18.7M
$13.3M
OCUL
Higher net margin
HCWC
HCWC
479.1% more per $
HCWC
-8.9%
-488.0%
OCUL
More free cash flow
HCWC
HCWC
$56.2M more FCF
HCWC
$-927.1K
$-57.1M
OCUL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCWC
HCWC
OCUL
OCUL
Revenue
$18.7M
$13.3M
Net Profit
$-1.7M
$-64.7M
Gross Margin
39.1%
88.0%
Operating Margin
-7.6%
-526.5%
Net Margin
-8.9%
-488.0%
Revenue YoY
-22.4%
Net Profit YoY
-33.6%
EPS (diluted)
$-0.05
$-0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCWC
HCWC
OCUL
OCUL
Q4 25
$18.7M
$13.3M
Q3 25
$19.0M
$14.5M
Q2 25
$20.2M
$13.5M
Q1 25
$20.3M
$10.7M
Q4 24
$17.1M
Q3 24
$18.2M
$15.4M
Q2 24
$16.4M
Q1 24
$14.8M
Net Profit
HCWC
HCWC
OCUL
OCUL
Q4 25
$-1.7M
$-64.7M
Q3 25
$-1.2M
$-69.4M
Q2 25
$-339.4K
$-67.8M
Q1 25
$-712.4K
$-64.1M
Q4 24
$-48.4M
Q3 24
$-2.7M
$-36.5M
Q2 24
$-43.8M
Q1 24
$-64.8M
Gross Margin
HCWC
HCWC
OCUL
OCUL
Q4 25
39.1%
88.0%
Q3 25
38.8%
87.8%
Q2 25
40.1%
85.6%
Q1 25
38.8%
88.2%
Q4 24
92.8%
Q3 24
38.4%
89.9%
Q2 24
90.8%
Q1 24
91.0%
Operating Margin
HCWC
HCWC
OCUL
OCUL
Q4 25
-7.6%
-526.5%
Q3 25
-3.2%
-472.3%
Q2 25
-0.2%
-502.6%
Q1 25
-2.0%
-597.5%
Q4 24
-296.1%
Q3 24
-2.0%
-298.2%
Q2 24
-265.1%
Q1 24
-214.0%
Net Margin
HCWC
HCWC
OCUL
OCUL
Q4 25
-8.9%
-488.0%
Q3 25
-6.4%
-477.3%
Q2 25
-1.7%
-503.9%
Q1 25
-3.5%
-598.7%
Q4 24
-283.3%
Q3 24
-14.6%
-236.6%
Q2 24
-266.3%
Q1 24
-438.9%
EPS (diluted)
HCWC
HCWC
OCUL
OCUL
Q4 25
$-0.05
$-0.27
Q3 25
$-0.09
$-0.38
Q2 25
$-0.03
$-0.39
Q1 25
$-0.07
$-0.38
Q4 24
$-0.25
Q3 24
$-0.29
$-0.22
Q2 24
$-0.26
Q1 24
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCWC
HCWC
OCUL
OCUL
Cash + ST InvestmentsLiquidity on hand
$3.0M
$737.1M
Total DebtLower is stronger
$7.3M
Stockholders' EquityBook value
$7.3M
$654.3M
Total Assets
$33.5M
$808.1M
Debt / EquityLower = less leverage
1.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCWC
HCWC
OCUL
OCUL
Q4 25
$3.0M
$737.1M
Q3 25
$3.0M
$344.8M
Q2 25
$4.7M
$391.1M
Q1 25
$1.8M
$349.7M
Q4 24
$392.1M
Q3 24
$1.8M
$427.2M
Q2 24
$459.7M
Q1 24
$482.9M
Total Debt
HCWC
HCWC
OCUL
OCUL
Q4 25
$7.3M
Q3 25
$8.5M
Q2 25
$9.7M
Q1 25
$10.6M
Q4 24
Q3 24
$11.6M
Q2 24
Q1 24
Stockholders' Equity
HCWC
HCWC
OCUL
OCUL
Q4 25
$7.3M
$654.3M
Q3 25
$5.9M
$258.2M
Q2 25
$5.8M
$305.9M
Q1 25
$2.1M
$265.9M
Q4 24
$315.3M
Q3 24
$2.9M
$352.0M
Q2 24
$377.7M
Q1 24
$408.0M
Total Assets
HCWC
HCWC
OCUL
OCUL
Q4 25
$33.5M
$808.1M
Q3 25
$33.7M
$410.9M
Q2 25
$36.4M
$451.3M
Q1 25
$34.1M
$405.9M
Q4 24
$457.9M
Q3 24
$33.2M
$490.4M
Q2 24
$517.1M
Q1 24
$538.9M
Debt / Equity
HCWC
HCWC
OCUL
OCUL
Q4 25
1.00×
Q3 25
1.43×
Q2 25
1.69×
Q1 25
5.01×
Q4 24
Q3 24
3.95×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCWC
HCWC
OCUL
OCUL
Operating Cash FlowLast quarter
$-855.1K
$-54.2M
Free Cash FlowOCF − Capex
$-927.1K
$-57.1M
FCF MarginFCF / Revenue
-5.0%
-430.9%
Capex IntensityCapex / Revenue
0.4%
21.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$675.4K
$-216.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCWC
HCWC
OCUL
OCUL
Q4 25
$-855.1K
$-54.2M
Q3 25
$-308.7K
$-50.7M
Q2 25
$1.1M
$-55.2M
Q1 25
$1.1M
$-44.7M
Q4 24
$-39.4M
Q3 24
$-36.6M
Q2 24
$-24.8M
Q1 24
$-33.9M
Free Cash Flow
HCWC
HCWC
OCUL
OCUL
Q4 25
$-927.1K
$-57.1M
Q3 25
$-351.3K
$-56.7M
Q2 25
$988.6K
$-56.5M
Q1 25
$965.3K
$-46.6M
Q4 24
$-39.6M
Q3 24
$-36.6M
Q2 24
$-25.5M
Q1 24
$-34.1M
FCF Margin
HCWC
HCWC
OCUL
OCUL
Q4 25
-5.0%
-430.9%
Q3 25
-1.8%
-390.0%
Q2 25
4.9%
-419.7%
Q1 25
4.8%
-435.6%
Q4 24
-232.0%
Q3 24
-237.6%
Q2 24
-155.4%
Q1 24
-231.1%
Capex Intensity
HCWC
HCWC
OCUL
OCUL
Q4 25
0.4%
21.4%
Q3 25
0.2%
41.2%
Q2 25
0.4%
9.3%
Q1 25
0.6%
18.1%
Q4 24
1.2%
Q3 24
0.6%
Q2 24
4.5%
Q1 24
1.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCWC
HCWC

Retail Grocery$17.1M91%
Food Service Restaurant$1.7M9%

OCUL
OCUL

Segment breakdown not available.

Related Comparisons